Phaarmasia share news and announcements
BSE: 523620Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹87.97.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹62 Cr3,202nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 14 Aug 2026
- 3.5
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹19 crore of one-off items, the largest of them in the quarter to Dec 2025.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 2.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- 114.5%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹19 crore of one-off items, the largest of them in the quarter to Dec 2025.
- −8.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 7.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.05
- Volume, BSEVolume. Shares traded on the last trading day.
- 231
Phaarmasia share news and announcements
400 announcements, routine notices left out, newest first. Page 3 of 8.
May 2023
17 May · Board meeting
Meeting on 25 May 2023: audited results
Apr 2023
29 Apr · Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015-Reg
26 Apr · Certificate In Terms Of Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Mar 2023
Feb 2023
23 Feb · Post-Offer Public Announcement
21 Feb · Outcome of Reverse Book Building Process
10 Feb · Submission Of Recommendation Of The Committee Of Independent Directors Pursuant To Regulation 28 Of Delisting Regulations ("Recommendation Of IDC")
9 Feb · Submission Of Letter Of Offer By Phaarmasia Limited ("Company") In Accordance With The Provisions Under The SEBI (Delisting Of Equity Shares) Regulations, 2021 And SEBI (Listing Obligations And Disclosure Requirements}, Regulations, 2015
6 Feb · Board meeting
Meeting on 13 Feb 2023: quarterly results6 Feb · Detailed Public Announcement (Delisting Offer)
Dec 2022
Nov 2022
22 Nov · Announcement under Regulation 30 (LODR)-Meeting Updates
17 Nov · Intimation Under Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended- Proposal For Voluntary Delisting Of Equity Shares Of Phaarmasia Limited In Terms Of Securities And Exchange Board Of India (Delisting Of Equity Shares) Regulations, 2021, As Amended, ('Delisting Regulations'), ('Delisting Proposal')
17 Nov · Notice To BSE Limited Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
17 Nov · Updates on Delisting Offer
16 Nov · Outcome Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended- Proposal For Voluntary Delisting Of Equity Shares Of Phaarmasia Limited
11 Nov · Board meeting
Meeting on 16 Nov 2022: voluntary delisting of shares11 Nov · Announcement under Regulation 30 (LODR)-Public Announcement-Delisting
11 Nov · Announcement under Regulation 30 (LODR)-Public Announcement-Delisting
11 Nov · Announcement under Regulation 30 (LODR)-Public Announcement-Delisting
7 Nov · Board meeting
Meeting on 14 Nov 2022: quarterly results
Oct 2022
7 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2022
Aug 2022
2 Aug · Board meeting
Meeting on 12 Aug 2022: quarterly results and annual general meeting
Jul 2022
20 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
May 2022
20 May · Board meeting
Meeting on 27 May 2022: audited results and quarterly results